Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Admetsys

Admetsys
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Corporate LATEST DEAL TYPE
13 INVESTORS
Description

Developer of a blood-sugar management system designed to control blood sugar in Type-1 diabetes patients. The company's Automated Insulin Delivery (AID) system uses a standard IV line, which draws a small blood sample (less than a mL) every few minutes, from which it measures glucose electro-chemically and returns the blood back to the patient enabling hospitals to more effectively control blood glucose levels and alleviate some of the stresses associated with diabetic care in the hospital environment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 21 Drydock Avenue
  • 6th Floor
  • Boston, MA 02210
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Admetsys’s full profile, request a free trial.

Admetsys Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Corporate 06-Jun-2017 00.000 Completed Clinical Trials - General
9. Early Stage VC 27-Apr-2017 00000 00.000 Completed Clinical Trials - General
8. Accelerator/Incubator 28-Jun-2016 00.000 Completed Clinical Trials - General
7. Accelerator/Incubator 08-Mar-2016 000 00.000 Completed Clinical Trials - General
6. Accelerator/Incubator 29-Jul-2015 000.00 Completed Clinical Trials - General
5. Accelerator/Incubator 24-Jun-2015 000.00 Completed Clinical Trials - General
4. Grant 15-Apr-2015 00.00 000.00 Completed Clinical Trials - General
3. Accelerator/Incubator 09-Mar-2015 000.00 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Dec-2014 $37.4K $37.4K Completed Clinical Trials - General
1. Accelerator/Incubator 21-May-2014 Completed Clinical Trials - General
To view this company’s complete deal history including valuation and funding, request access »

Admetsys Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtronic Corporation Minneapolis, MN 00000 00000000
000000 Formerly VC-backed Rydalmere, Australia 00 000.00 000000000 000.00
00000000 00000 Private Equity-Backed Tampa, FL 000.00 000000000000 000.00
000 00000000000 Private Equity-Backed Indianapolis, IN 000 00 000000
To view this company’s complete list of competitors, request access »

Admetsys Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
T1D Exchange Corporation Minority 000 0000 000000 0
Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies University Minority 000 0000 000000 0
TiE-Boston Accelerator/Incubator 000 0000 000000 0
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
DreamIt Ventures Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Admetsys Executive Team (3)

Name Title Board
Seat
Contact
Info
Jeffrey Valk Co-Founder and Chief Executive Officer
Glenn Robertelli Co-Founder & Chief Operating Officer
Tim Valk MD Chief Scientist